PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow PACS
PACS Group, Inc. (PACS) P/E ratio
As of 16 October 2026, PACS Group, Inc. (PACS) trades at a P/E ratio of 27.6×. Over the past ten years it has ranged from 9.0× (September 2025) to 102× (November 2024); the current reading is higher than 40% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 31.5× | (2.26%) |
| FY2024 | 32.2× | 19.73% |
| FY2023 | 26.9× | 0.00% |
| FY2022 | 26.9× | 0.00% |
| FY2021 | 26.9× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 25.1× | 21.04% |
| Mar 2026 | 20.7× | (34.15%) |
| Dec 2025 | 31.5× | 149.81% |
| Sep 2025 | 12.6× | (16.15%) |
| 10 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| UHS Universal Health Services, Inc. compare | 7.5× |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 11.5× |
| DVA DaVita Inc. compare | 15.0× |
| OPCH Option Care Health, Inc. compare | 23.5× |
| CON Concentra Group Holdings Parent, Inc. compare | 24.9× |
| CHE Chemed Corporation compare | 25.7× |
| ENSG The Ensign Group, Inc. compare | 26.9× |
| PACS PACS Group, Inc. | 27.6× |
| LFST LifeStance Health Group, Inc. compare | 88.3× |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)